We demonstrated that DDX3X, a female-biased gene in TAM-MGs and Xi-expressed in a number of human tissues, is a key modulator of IFN-stimulated genes, thereby representing a candidate genetic driver of enhanced anti-tumor immunity and better GBM outcomes in females. The gene discussed is DDX3X; the disease is glioblastoma.